Table 1

Characteristics of 126 patients with ankylosing spondylitis

Men % (n)

70.6 (89)

Age* (years)

45.9 ± 11.5

Symptom duration* (years)

8.1 ± 7.4

Disease duration* (years)

14.7 ± 10.0

Current medication % (n)

None

12.7 (16)

NSAIDs

61.9 (78)

Biologicals

4.0 (5)

Combination

10.3 (13)

Other#

4.0 (5)

HLA-B27+ % (n)

77.8 (98)

ESR* (mm/hour)

10.4 ± 18.4

Extra-spinal symptoms % (n)

psoriasis

4.8 (6)

uveitis

19.8 (25)

inflammatory bowel disease

4.0 (5)

arthritis

38.1 (48)

BASFI* (score 0-10)

4.9 ± 2.3

BASDAI* (score 0-10)

5.2 ± 2.3

BASMI* (score 0-10)

4.1 ± 2.0


* mean ± standard deviation

# e.g. sulfasalazine, methotrexate.

BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath Ankylosing Spondylitis Functional Index; BASMI, Bath Ankylosing Spondylitis Metrology Index; ESR, { Erythrocyte Sedimentation Rate NSAIDs, non-steroidal antiinflammatory drugs.

van Weely et al. Arthritis Research & Therapy 2012 14:R52   doi:10.1186/ar3765

Open Data